Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins

An explanation for the higher incidence of cardiovascular disease and heart failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) with doxazosin and the Vasodilator Heart Failure Trial (V-HeFT) with prazosin might be decreased expression of heat shock pr...

Descripción completa

Detalles Bibliográficos
Autor principal: Hooper, Philip L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64823/
https://www.ncbi.nlm.nih.gov/pubmed/11806806
http://dx.doi.org/10.1186/cvm-2-6-251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64823/
https://www.ncbi.nlm.nih.gov/pubmed/11806806
http://dx.doi.org/10.1186/cvm-2-6-251

Ejemplares similares